Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1511-1520 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|November 25, 2010
Sequencing antibody repertoires: the next generationNicolas Fischer
Mabs|November 4, 2011
Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodiesImre Kacskovics, Judit Cervenak, Anna Erdei, et al.
Mabs|January 6, 2017
A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvsSarah-Jane Kellmann, Stefan Dübel, Holger Thie
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Mabs|March 28, 2014
Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signalingStevan Shaw, Tim Bourne, Chris Meier, et al.
Mabs|March 28, 2014
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacyAngeline X H Goh, Sebastien Bertin-Maghit, Siok Ping Yeo, et al.
Mabs|May 8, 2014
Characterization and screening of IgG binding to the neonatal Fc receptorTobias Neuber, Katrin Frese, Jan Jaehrling, et al.
Mabs|October 18, 2016
Broad epitope coverage of a human in vitro antibody libraryArvind Sivasubramanian, Patricia Estep, Heather Lynaugh, et al.
Mabs|June 6, 2012
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314Ralf Kircheis, Nicole Halanek, Iris Koller, et al.
Mabs|November 22, 2013
Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversityMaria A T Groves, Lily Amanuel, Jamie I Campbell, et al.
Pageof 178

Showing results (1511-1520 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|November 25, 2010
Sequencing antibody repertoires: the next generationNicolas Fischer
Mabs|November 4, 2011
Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodiesImre Kacskovics, Judit Cervenak, Anna Erdei, et al.
Mabs|January 6, 2017
A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvsSarah-Jane Kellmann, Stefan Dübel, Holger Thie
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Mabs|March 28, 2014
Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signalingStevan Shaw, Tim Bourne, Chris Meier, et al.
Mabs|March 28, 2014
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacyAngeline X H Goh, Sebastien Bertin-Maghit, Siok Ping Yeo, et al.
Mabs|May 8, 2014
Characterization and screening of IgG binding to the neonatal Fc receptorTobias Neuber, Katrin Frese, Jan Jaehrling, et al.
Mabs|October 18, 2016
Broad epitope coverage of a human in vitro antibody libraryArvind Sivasubramanian, Patricia Estep, Heather Lynaugh, et al.
Mabs|June 6, 2012
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314Ralf Kircheis, Nicole Halanek, Iris Koller, et al.
Mabs|November 22, 2013
Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversityMaria A T Groves, Lily Amanuel, Jamie I Campbell, et al.
Pageof 178